| Type I IFNs promote cancer cell stemness by triggering the epigenetic regulator KDM1B M Musella, A Guarracino, N Manduca, C Galassi, E Ruggiero, A Potenza, ... Nature immunology 23 (9), 1379-1392, 2022 | 77 | 2022 |
| Kinase-independent inhibition of cyclophosphamide-induced pathways protects the ovarian reserve and prolongs fertility G Bellusci, L Mattiello, V Iannizzotto, S Ciccone, E Maiani, V Villani, ... Cell Death & Disease 10 (10), 726, 2019 | 49 | 2019 |
| Control of replication stress and mitosis in colorectal cancer stem cells through the interplay of PARP1, MRE11 and RAD51 G Manic, M Musella, F Corradi, A Sistigu, S Vitale, ... Cell Death & Differentiation 28 (7), 2060-2082, 2021 | 25 | 2021 |
| The targeting of mre11 or rad51 sensitizes colorectal cancer stem cells to chk1 inhibition L Mattiello, S Soliman Abdel Rehim, M Musella, A Sistigu, A Guarracino, ... Cancers 13 (8), 1957, 2021 | 13 | 2021 |
| Asciminib mitigates DNA damage stress signaling induced by cyclophosphamide in the ovary L Mattiello, G Pucci, F Marchetti, M Diederich, S Gonfloni International Journal of Molecular Sciences 22 (3), 1395, 2021 | 12 | 2021 |
| Assessment of cell cycle progression and mitotic slippage by videomicroscopy L Mattiello, SSA Rehim, G Manic, I Vitale Methods in Cell Biology 181, 43-58, 2024 | 1 | 2024 |
| Author Correction: Type I IFNs promote cancer cell stemness by triggering the epigenetic regulator KDM1B M Musella, A Guarracino, N Manduca, C Galassi, E Ruggiero, A Potenza, ... Nature Immunology 25 (11), 2166, 2024 | | 2024 |
| The Targeting of MRE11 or RAD51 Sensitizes Colorectal Cancer Stem Cells to CHK1 Inhibition. Cancers 2021, 13, 1957 L Mattiello, S Soliman Abdel Rehim, M Musella, A Sistigu, A Guarracino, ... s Note: MDPI stays neutral with regard to jurisdictional claims in published …, 2021 | | 2021 |
